BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 6846276)

  • 1. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R; Kelly HW; Howick J; McWilliams BC
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Theolair SR and Theo-Dur tablets.
    Domson JF; Hein EW; Sheen A; Sly RM
    Ann Allergy; 1979 Oct; 43(4):220-2. PubMed ID: 555598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-a-day dosing with theophylline: a comparison of four sustained-release products.
    Minotti DA; Altman LC; Ayars GH; Popick FR; Benn VJ
    Ann Allergy; 1992 Jun; 68(6):500-6. PubMed ID: 1610026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
    Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets.
    Kelly HW; Murphy S
    Am J Hosp Pharm; 1979 Dec; 36(12):1698-701. PubMed ID: 525646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new sustained-release theophylline suspension for asthmatic children: evaluation of serum theophylline concentrations.
    Boner AL; Vallone G; Valletta E; Bernocchi D; Plebani M
    Int J Clin Pharmacol Res; 1987; 7(5):345-50. PubMed ID: 3667007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ; Demers L; Esler V; Field E
    Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release theophylline therapy for chronic childhood asthma.
    Bell T; Bigley J
    Pediatrics; 1978 Sep; 62(3):352-8. PubMed ID: 704210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical effect of sustained-release theophylline (Theo-Dur) for asthmatic children and serum theophylline level (author's transl)].
    Masaki T; Sekine H; Nagakura T; Iikura Y; Tomita Y; Asano T; Kajita T; Seo K
    Arerugi; 1981 Apr; 30(4):190-6. PubMed ID: 7337549
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
    Brown DL; Maddux MS; Organek HW; Bauman JL
    Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration.
    Katz RM; Rachelefsky GS; Siegel SC; Mickey R
    Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics.
    Arkinstall WW; Atkins ME; Harrison D; Stewart JH
    Am Rev Respir Dis; 1987 Feb; 135(2):316-21. PubMed ID: 3813191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ; Cefali EA; Straughn AB
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic equivalence of a generic slow-release theophylline tablet.
    Hendeles L; Breton AL; Beaty R; Harman E
    Pharmacotherapy; 1995; 15(1):26-35. PubMed ID: 7739942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.